Videos / Weight management and cardiovascular risk reduction: The role of Semaglutide 2.4mg
In this Product Explainer, Dr. Robert Hungerford, GP with a special interest in ASCVD, heart failure and diabetes, explains the role of Semaglutide 2.4mg in weight management and cardiovascular risk reduction in secondary prevention (7 mins).

Autism Spectrum Disorder – Managing Challenging Behaviours

Paediatric Allergic Rhinitis & Immunotherapy

Premature Ovarian Insufficiency – The New Guidelines

Alcohol Addiction Assessment and Advice

expert
GP Supervisor with a special interest in Heart Failure, ASCVD and Diabetes, Marketown Health; Conjoint lecturer, University of Newcastle